Voutsadakis Ioannis A, Silverman Lewis R
Division of Hematology, Division of Medical Oncology, Department of Medicine, Mount Sinai Hospital, Mount Sinai School of Medicine, New York, New York, USA.
Cancer Invest. 2002;20(4):452-7. doi: 10.1081/cnv-120002144.
Only 16 cases of breast carcinoma in human immunodeficiency virus (HIV) seropositive patients have been reported in the literature. We report four cases of breast cancer in women seropositive for the HIV and review the literature. Breast cancer is not an acquired immunodeficiency syndrome (AIDS)-defining disease and its incidence is not increased in HIV patients. Most patients reported had a CD4 count, which was above the threshold considered critical for significant immunosuppression suggesting that, HIV related immunocompromise does not have a direct tumorigenic role. Alternatively, the biology of breast cancer appears to be more aggressive in HIV-positive women suggesting a permissive role of the virus in the progression of the cancer. The aggressiveness of the breast carcinoma in HIV-positive women justifies every effort to preserve the dose intensity of treatment in those patients, especially in the current era of more effective HIV treatment which leads to improved survival.
文献中仅报道了16例人类免疫缺陷病毒(HIV)血清阳性患者患乳腺癌的病例。我们报告了4例HIV血清阳性女性乳腺癌病例并复习文献。乳腺癌并非获得性免疫缺陷综合征(AIDS)的定义性疾病,HIV患者中其发病率并未增加。大多数报道的患者CD4计数高于被认为对显著免疫抑制至关重要的阈值,这表明HIV相关免疫功能低下并无直接致瘤作用。另外,乳腺癌生物学行为在HIV阳性女性中似乎更具侵袭性,提示病毒在癌症进展中起促进作用。HIV阳性女性乳腺癌的侵袭性说明应尽一切努力维持这些患者的治疗剂量强度,尤其是在当前HIV治疗更有效的时代,这可提高生存率。